Screener
Parabilis Medicines PBLS Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | ||
|---|---|---|---|---|---|
| $2.11M— | $148K— | —— | $0— | ||
| $45.6M— | $39.38M+30.7% | —— | $30.13M— | ||
| $11.25M— | $11.66M+82.3% | —— | $6.39M— | ||
| $56.85M— | $51.03M+39.7% | —— | $36.52M— | ||
| -$54.74M— | -$50.89M-39.3% | —— | -$36.52M— | ||
| -2,589.2%— | -34,382.4%— | —— | —— | ||
| $124K— | $210K-47.0% | —— | $396K— | ||
| $10.25M— | -$1.58M-192% | —— | $1.71M— | ||
| -$44.49M— | -$52.46M-50.7% | -$45.32M-18.2% | -$34.81M— | ||
| -2,104.6%— | -35,448%— | —— | —— | ||
| -$0.36— | -$2.32+89.6% | —— | -$22.28— | ||
| -$54.13M— | —— | —— | —— | ||
| -2,560.7%— | —— | —— | —— | ||
| -$54.74M— | -$50.89M-39.3% | —— | -$36.52M— |
FAQ
- Where does Parabilis Medicines's income statement data come from?
- Every line is extracted from Parabilis Medicines's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.